- Home
- PNTG vs NBTX Comparison
PNTG vs NBTX Comparison
Compare PNTG & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNTG
- NBTX
- Stock Information
- Founded
- PNTG 2019
- NBTX 2003
- Country
- PNTG United States
- NBTX France
- Employees
- PNTG N/A
- NBTX N/A
- Industry
- PNTG Medical/Nursing Services
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- PNTG Health Care
- NBTX Health Care
- Exchange
- PNTG Nasdaq
- NBTX Nasdaq
- Market Cap
- PNTG 833.6M
- NBTX 868.8M
- IPO Year
- PNTG N/A
- NBTX 2020
- Fundamental
- Price
- PNTG $25.03
- NBTX $20.78
- Analyst Decision
- PNTG Buy
- NBTX Strong Buy
- Analyst Count
- PNTG 6
- NBTX 1
- Target Price
- PNTG $35.00
- NBTX $8.00
- AVG Volume (30 Days)
- PNTG 274.9K
- NBTX 112.7K
- Earning Date
- PNTG 11-05-2025
- NBTX 09-30-2025
- Dividend Yield
- PNTG N/A
- NBTX N/A
- EPS Growth
- PNTG 20.56
- NBTX N/A
- EPS
- PNTG 0.77
- NBTX N/A
- Revenue
- PNTG $798,923,000.00
- NBTX $11,930,711.00
- Revenue This Year
- PNTG $28.29
- NBTX N/A
- Revenue Next Year
- PNTG $11.53
- NBTX $74.67
- P/E Ratio
- PNTG $33.50
- NBTX N/A
- Revenue Growth
- PNTG 30.58
- NBTX N/A
- 52 Week Low
- PNTG $21.18
- NBTX $2.76
- 52 Week High
- PNTG $36.20
- NBTX $22.51
- Technical
- Relative Strength Index (RSI)
- PNTG 51.65
- NBTX 72.77
- Support Level
- PNTG $24.71
- NBTX $19.11
- Resistance Level
- PNTG $26.42
- NBTX $22.64
- Average True Range (ATR)
- PNTG 0.77
- NBTX 1.64
- MACD
- PNTG 0.06
- NBTX 0.64
- Stochastic Oscillator
- PNTG 50.00
- NBTX 84.83
About PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.